BYMA to base its entire post-trade ecosystem on Nasdaq technology Argentinian exchange group to adopt Nasdaq’s real-time clearing platform, expanding […]
ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated […]